These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31785579)

  • 1. Prognostic Potential of Alternative Splicing Markers in Endometrial Cancer.
    Wang Q; Xu T; Tong Y; Wu J; Zhu W; Lu Z; Ying J
    Mol Ther Nucleic Acids; 2019 Dec; 18():1039-1048. PubMed ID: 31785579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer.
    Chen P; He J; Ye H; Jiang S; Li Y; Li X; Wan J
    Front Genet; 2020; 11():456. PubMed ID: 32547595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-Wide Profiling of Prognostic Alternative Splicing Signature in Colorectal Cancer.
    Zong Z; Li H; Yi C; Ying H; Zhu Z; Wang H
    Front Oncol; 2018; 8():537. PubMed ID: 30524964
    [No Abstract]   [Full Text] [Related]  

  • 4. Alternative splicing-related factor YT521: an independent prognostic factor in endometrial cancer.
    Zhang B; zur Hausen A; Orlowska-Volk M; Jäger M; Bettendorf H; Stamm S; Hirschfeld M; Yiqin O; Tong X; Gitsch G; Stickeler E
    Int J Gynecol Cancer; 2010 May; 20(4):492-9. PubMed ID: 20686370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic profiling of a novel prognostic alternative splicing signature in hepatocellular carcinoma.
    Zhang D; Duan Y; Wang Z; Lin J
    Oncol Rep; 2019 Dec; 42(6):2450-2472. PubMed ID: 31578577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel alternative splicing-based prediction model for uteri corpus endometrial carcinoma.
    Gao L; Xie ZC; Pang JS; Li TT; Chen G
    Aging (Albany NY); 2019 Jan; 11(1):263-283. PubMed ID: 30640723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma.
    Wan Q; Sang X; Jin L; Wang Z
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32098099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic profiling of alternative splicing signature reveals prognostic predictor for prostate cancer.
    Zhao J; Chang L; Gu X; Liu J; Sun B; Wei X
    Cancer Sci; 2020 Aug; 111(8):3020-3031. PubMed ID: 32530556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of DNA methylation markers for diagnosis and prognosis of patients with endometrial cancer.
    Ying J; Xu T; Wang Q; Ye J; Lyu J
    Epigenetics; 2018; 13(5):490-504. PubMed ID: 29912667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma.
    Liu Y; Jia W; Li J; Zhu H; Yu J
    Front Oncol; 2020; 10():587343. PubMed ID: 33117720
    [No Abstract]   [Full Text] [Related]  

  • 11. Comprehensive investigation of alternative splicing and development of a prognostic risk score for prostate cancer based on six-gene signatures.
    Cao ZX; Xiao GA; Zhang W; Ji J; Ye C; Liu D; Tian QQ; Prof YS
    J Cancer; 2019; 10(22):5585-5596. PubMed ID: 31632503
    [No Abstract]   [Full Text] [Related]  

  • 12. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
    Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
    J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative splicing of synuclein gamma in endometrial cancer: identification of a novel isoform.
    Schaal K; Hirschfeld M; Bronsert P; Füllgraf H; Jäger M; Herde B; Nöthling C; Mayer S; Erbes T; Stickeler E
    Oncotarget; 2015 Sep; 6(26):22553-63. PubMed ID: 26265438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value and Potential Regulatory Mechanism of Alternative Splicing in Geriatric Breast Cancer.
    Li X; Wang Y; Li B; Ma W
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32079071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas.
    Yang X; Huang WT; He RQ; Ma J; Lin P; Xie ZC; Ma FC; Chen G
    J Transl Med; 2019 Aug; 17(1):283. PubMed ID: 31443718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
    He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
    Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
    Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G
    Gene; 2019 May; 697():86-93. PubMed ID: 30779946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic alternative splicing regulatory network of splicing events in acute myeloid leukemia patients based on SpliceSeq data from 136 cases.
    Xie ZC; Gao L; Chen G; Ma J; Yang LH; He RQ; Li MW; Cai KT; Li TT; Peng ZG
    Neoplasma; 2020 May; 67(3):623-635. PubMed ID: 32039631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic Profile Analysis of Prognostic Alternative Messenger RNA Splicing Signatures and Splicing Factors in Head and Neck Squamous Cell Carcinoma.
    Xing L; Zhang X; Tong D
    DNA Cell Biol; 2019 Jul; 38(7):627-638. PubMed ID: 31025877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and genes associated with endometrial cancer based on gene expression profiling by bioinformatics analysis.
    Zhang Y; Zhang W; Li X; Li D; Zhang X; Yin Y; Deng X; Sheng X
    Arch Gynecol Obstet; 2016 Jun; 293(6):1287-95. PubMed ID: 26437953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.